Moderna establishes public health-focused charity; FDA approves AstraZeneca diabetes drug for pediatric use
To help promote public health and healthcare in underserved areas of the world, Moderna will establish a charity with a $50 million endowment.
The Cambridge, MA-based company announced the board of directors’ approval Thursday. The foundation will focus on “charitable, scientific and educational endeavors” with an emphasis on promoting public health and the access to healthcare, the press release said. The foundation will start operations once its status as a 501(c)(3) is approved.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.